Unknown

Dataset Information

0

MiR-181c-5p Promotes Inflammatory Response during Hypoxia/Reoxygenation Injury by Downregulating Protein Tyrosine Phosphatase Nonreceptor Type 4 in H9C2 Cardiomyocytes.


ABSTRACT: Background:Constitutive nuclear factor kappa B (NF?B) activation has been shown to exacerbate during myocardial ischemia/reperfusion (I/R) injury. We recently showed that miR-181c-5p exacerbated cardiomyocytes injury and apoptosis by directly targeting the 3'-untranslated region of protein tyrosine phosphatase nonreceptor type 4 (PTPN4). However, whether miR-181c-5p mediates cardiac I/R injury through NF?B-mediated inflammation is unknown. Thus, the present study aimed to investigate the role of miR-181c-5p during myocardial I/R injury and explore its mechanism in relation to inflammation in H9C2 cardiomyocytes. Methods and Results:In hypoxia/reoxygenation (H/R, 6?h hypoxia followed by 6?h reoxygenation)-stimulated H9C2 cardiomyocytes or postischemic myocardium of rat, the expression of miR-181c-5p was significantly upregulated, which was concomitant increased NF?B activity when compared to the nonhypoxic or nonischemic control groups. This is indicative that miR-181c-5p may be involved in NF?B-mediated inflammation during myocardial I/R injury. To investigate the potential role of miR-181c-5p in H/R-induced cell inflammation and injury, H9C2 cardiomyocytes were transfected with the miR-181c-5p agomir. Overexpression of miR-181c-5p significantly aggravated H/R-induced cell injury (increased lactate dehydrogenase (LDH) level) and exacerbated NF?B-mediated inflammation (greater phosphorylation and degradation of I?B?, phosphorylation of p65, and increased levels of proinflammatory cytokines tumor necrosis factor ? (TNF?), interleukin (IL)-6, and IL-1?). In contrast, inhibition of miR-181c-5p by its antagomir transfection in vitro had the opposite effect. Furthermore, overexpression of miR-181c-5p significantly enhanced lipopolysaccharide-induced NF?B signalling. Additionally, knockdown of PTPN4, the direct target of miR-181c-5p, significantly aggravated H/R-induced phosphorylation and degradation of I?B?, phosphorylation of p65, and the levels of proinflammatory cytokines. PTPN4 knockdown also cancelled miR-181c-5p antagomir mediated anti-inflammatory effects in H9C2 cardiomyocytes during H/R injury. Conclusions:It is concluded that miR-181c-5p may exacerbate myocardial I/R injury and NF?B-mediated inflammation via PTPN4, and that targeting miR-181c-5p/PTPN4/NF?B signalling may represent a novel strategy to combat myocardial I/R injury.

SUBMITTER: Wang S 

PROVIDER: S-EPMC7399766 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

MiR-181c-5p Promotes Inflammatory Response during Hypoxia/Reoxygenation Injury by Downregulating Protein Tyrosine Phosphatase Nonreceptor Type 4 in H9C2 Cardiomyocytes.

Wang Sheng S   Ge Liang L   Zhang Dengwen D   Wang Lin L   Liu Hao H   Ye Xiaodong X   Liang Wanling W   Li Jun J   Ma Haichun H   Cai Yin Y   Xia Zhengyuan Z  

Oxidative medicine and cellular longevity 20200725


<h4>Background</h4>Constitutive nuclear factor kappa B (NF<i>κ</i>B) activation has been shown to exacerbate during myocardial ischemia/reperfusion (I/R) injury. We recently showed that miR-181c-5p exacerbated cardiomyocytes injury and apoptosis by directly targeting the 3'-untranslated region of protein tyrosine phosphatase nonreceptor type 4 (PTPN4). However, whether miR-181c-5p mediates cardiac I/R injury through NF<i>κ</i>B-mediated inflammation is unknown. Thus, the present study aimed to i  ...[more]

Similar Datasets

| S-EPMC9278962 | biostudies-literature
| S-EPMC4854406 | biostudies-literature
| S-EPMC6273835 | biostudies-literature
| S-EPMC6222483 | biostudies-literature
| S-EPMC6580049 | biostudies-literature
| S-EPMC5914297 | biostudies-literature
| S-EPMC7759118 | biostudies-literature
| S-EPMC8185511 | biostudies-literature
| S-EPMC7197225 | biostudies-literature
| S-EPMC7773375 | biostudies-literature